The global defibrillators market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A defibrillator refers to a medical device that delivers a therapeutic shock to the patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia and pulseless ventricular tachycardia. It aids in restoring a normal heartbeat by sending electric pulses or shockwaves to the heart. Some of the common types of defibrillators include automated external defibrillators (AED), manual/wearable external defibrillators, implantable cardioverter defibrillators (ICDs) and transvenous or subcutaneous implantable cardioverter defibrillators. These devices are primarily used in hospitals, clinics, cardiac centers, home care settings and prehospital care settings.
The increasing prevalence of cardiovascular diseases (CVDs) and sudden cardiac arrest (SCA) across the globe is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other related ailments, such as diabetes, atherosclerosis, hypertension and stroke, which is facilitating the product adoption across both the developed and emerging nations. Furthermore, widespread adoption of ICDs across healthcare centers is also providing a boost to the market growth. Modern ICDs are integrated with innovative subcutaneous and transvenous patches that aid in improving the overall efficiency and level of comfort for the patient. Additionally, various technological advancements and the development of wearable cardioverter defibrillators (WCDs) that can aid in predicting the risks of SCAs, are also creating a positive impact on the market growth. Other factors, including the implementation of favorable policies to promote training and awareness regarding defibrillators, along with extensive research and development (R&D) activities and increasing government investments in the healthcare sector, are projected to drive the market further.
Breakup by Product Type:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. and Stryker Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at